Objective
(i)
Strengthening
the existing infrastructure facilities in order to make Indian Pharma Industry
a global leader in Pharma Sector.
(ii)
(ii) Easy
access to standard testing facilities and value addition in the domestic Pharma
Industry especially to SMEs through creation of common world class facilities
for increased competitiveness.
(iii)
(iii) To help
industry meet the requirements of standards of environment at a reduced cost
through innovative methods of common Waste Management System.
(iv)
(iv) Exploit
the benefits arising due to optimization of resources and economies of scale.
Scope and Coverage
Assistance under the Scheme will
be admissible for creation of Common Facilities by Government as well as
Private Entrepreneurs in pharma sector.
Common Facilities
Common Facilities under the
Sub-Scheme will consist of creation of tangible "assets" as Common
Facility Centers (CFCs). Some of the indicative activities under the Common
Facilities are:-
(i)
Common
Testing Centres
(ii)
(ii) Training
Centres
(iii)
(iii) R&D
Centres
(iv)
(iv) Effluent
Treatment Plants
(v)
(v) Common
Logistics Centres
The
above list of common facilities is illustrative and each cluster could have its
own specific requirement based on the nature of units being set up and the
products proposed to be manufactured. The Scheme Steering Committee (SSC) shall
approve the project components and funding thereof depending upon the merits of
the proposal.
Salient
Features of the Scheme
(i)
The land and
building for CFC shall be provided by SPV concerned as per cost indicated in
the detailed project report. In case the SPV provides an existing land and
building, the cost of the same will be decided on the basis of valuation report
prepared by an approved agency of Central/State Government
Departments/Financial Institutions (FIs)/Public Sector Banks and the cost of
land and building may be taken towards contribution for the project. Though the
land and building is included in the total project cost, however, the
Grant-in-Aid from GoI will not be utilized for these components.
(ii)
(ii)
Escalation in the cost of project over and above the sanctioned amount, due to
any reason will be borne by the SPV. The Central Government shall not accept
any financial liability arising out of operation of any CFC.
(iii)
(iii) The
Grant-in-Aid shall not be available to any individual production units, if any,
owned by a member of the SPV.
(iv)
(iv) The CFC
may be utilized by the SPV members and also by other pharma units on ‘user
charges’ basis to be decided by the SPV.
(v)
(v) User
charges for services of CFC shall be on differential rate basis, lower fee for
small units and higher fee for medium ones. However, the user charges will be
graded in such a manner that average charges will be lesser than prevailing
market prices, as decided by the Governing Council of the SPV. The SPV members
would be given reasonable preference in user charges.
(vi) (vi) An MoU shall be entered into among the GOI, the State Government concerned and the SPV for CFC projects
Financial Assistance
Maximum limit for the grant in
aid under this category would be Rs 20.00 crore per cluster or 70% of the cost
of project whichever is less.
The cost of project includes cost
of land, building, administrative and management support expenses including the
salary of CEO, engineers,
other experts and staff during
the project implementation period, preliminary expenses, machinery &
equipment, miscellaneous fixed assets and
other support infrastructure such
as water supply, electricity and margin money for working capital.
Grant-in-Aid from GoI will not
utilized towards land and building components of the project
Assistance for Administrative and
other management support of SPV during
the project implementation period
shall not exceed 5 % of the Grant-in-aid